Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 106

1.

Hypertension and longitudinal changes in cerebral blood flow: the SMART-MR study.

Muller M, van der Graaf Y, Visseren FL, Mali WP, Geerlings MI; SMART Study Group..

Ann Neurol. 2012 Jun;71(6):825-33. doi: 10.1002/ana.23554.

PMID:
22447734
2.

Longitudinal relationship between cerebral small-vessel disease and cerebral blood flow: the second manifestations of arterial disease-magnetic resonance study.

van der Veen PH, Muller M, Vincken KL, Hendrikse J, Mali WP, van der Graaf Y, Geerlings MI; SMART Study Group..

Stroke. 2015 May;46(5):1233-8. doi: 10.1161/STROKEAHA.114.008030.

3.

Total cerebral blood flow and hippocampal volume in patients with arterial disease. The SMART-MR study.

Knoops AJ, van der Graaf Y, Appelman AP, Mali WP, Geerlings MI.

J Cereb Blood Flow Metab. 2009 Oct;29(10):1727-33. doi: 10.1038/jcbfm.2009.91.

PMID:
19675562
4.

Blood Pressure Is Not Associated With Cerebral Blood Flow in Older Persons.

Foster-Dingley JC, Moonen JE, de Craen AJ, de Ruijter W, van der Mast RC, van der Grond J.

Hypertension. 2015 Nov;66(5):954-60. doi: 10.1161/HYPERTENSIONAHA.115.05799.

5.

Longitudinal MR imaging study in the prediction of ischemic susceptibility after cerebral hypoperfusion in rats: Influence of aging and hypertension.

Lee JT, Liu HL, Yang JT, Yang ST, Lin JR, Lee TH.

Neuroscience. 2014 Jan 17;257:31-40. doi: 10.1016/j.neuroscience.2013.10.066.

PMID:
24188793
6.

Blood pressure, cerebral blood flow, and brain volumes. The SMART-MR study.

Muller M, van der Graaf Y, Visseren FL, Vlek AL, Mali WP, Geerlings MI; SMART Study Group..

J Hypertens. 2010 Jul;28(7):1498-505. doi: 10.1097/HJH.0b013e32833951ef.

PMID:
20453669
7.

Blood pressure and progression of brain atrophy: the SMART-MR Study.

Jochemsen HM, Muller M, Visseren FL, Scheltens P, Vincken KL, Mali WP, van der Graaf Y, Geerlings MI; SMART Study Group..

JAMA Neurol. 2013 Aug;70(8):1046-53. doi: 10.1001/jamaneurol.2013.217.

PMID:
23753860
8.

Cerebral blood flow and metabolism in patients with silent brain infarction: occult misery perfusion in the cerebral cortex.

Nakane H, Ibayashi S, Fujii K, Sadoshima S, Irie K, Kitazono T, Fujishima M.

J Neurol Neurosurg Psychiatry. 1998 Sep;65(3):317-21.

9.

Hemodynamic influences of azelnidipine, a novel calcium channel blocker, on cerebral circulation in hypertensive patients with ischemic white matter lesions.

Kimura Y, Kitagawa K, Oku N, Kajimoto K, Kato H, Tanaka M, Sakaguchi M, Hougaku H, Sakoda S, Hatazawa J.

Hypertens Res. 2008 Dec;31(12):2147-54. doi: 10.1291/hypres.31.2147.

PMID:
19139604
10.

Longitudinal study of blood pressure and white matter hyperintensities: the EVA MRI Cohort.

Dufouil C, de Kersaint-Gilly A, Besançon V, Levy C, Auffray E, Brunnereau L, Alpérovitch A, Tzourio C.

Neurology. 2001 Apr 10;56(7):921-6.

PMID:
11294930
11.

Total cerebral blood flow, white matter lesions and brain atrophy: the SMART-MR study.

Appelman AP, van der Graaf Y, Vincken KL, Tiehuis AM, Witkamp TD, Mali WP, Geerlings MI; SMART Study Group..

J Cereb Blood Flow Metab. 2008 Mar;28(3):633-9.

PMID:
17912270
12.

[Profile on circadian blood pressure and the influencing factors in essential hypertensive patients after treatment].

Qiu YG, Yao XY, Tao QM, Zheng P, Chen JZ, Zhu JH, Zhang FR, Zheng LR, Zhao LL.

Zhonghua Liu Xing Bing Xue Za Zhi. 2004 Aug;25(8):710-4. Chinese.

PMID:
15555399
13.

Intensive blood pressure lowering increases cerebral blood flow in older subjects with hypertension.

Tryambake D, He J, Firbank MJ, O'Brien JT, Blamire AM, Ford GA.

Hypertension. 2013 Jun;61(6):1309-15. doi: 10.1161/HYPERTENSIONAHA.112.200972.

14.

Predictors of hypertension and changes of blood pressure in HIV-infected patients.

Thiébaut R, El-Sadr WM, Friis-Møller N, Rickenbach M, Reiss P, Monforte AD, Morfeldt L, Fontas E, Kirk O, De Wit S, Calvo G, Law MG, Dabis F, Sabin CA, Lundgren JD; Data Collection of Adverse events of anti-HIV Drugs Study Group..

Antivir Ther. 2005;10(7):811-23. Erratum in: Antivir Ther. 2005;10(8):969.

PMID:
16315369
15.

Olmesartan, an angiotensin II receptor blocker, restores cerebral hypoperfusion in elderly patients with hypertension.

Nagata R, Kawabe K, Ikeda K.

J Stroke Cerebrovasc Dis. 2010 May;19(3):236-40. doi: 10.1016/j.jstrokecerebrovasdis.2009.08.004.

PMID:
20434053
16.

Accuracy of Parenchymal Cerebral Blood Flow Measurements Using Pseudocontinuous Arterial Spin-Labeling in Healthy Volunteers.

Ambarki K, Wåhlin A, Zarrinkoob L, Wirestam R, Petr J, Malm J, Eklund A.

AJNR Am J Neuroradiol. 2015 Oct;36(10):1816-21. doi: 10.3174/ajnr.A4367.

17.

Ambulatory blood pressure and the brain: a 5-year follow-up.

Goldstein IB, Bartzokis G, Guthrie D, Shapiro D.

Neurology. 2005 Jun 14;64(11):1846-52.

PMID:
15955932
18.

Blood pressure and serum potassium levels in hypertensive patients receiving or not receiving antihypertensive treatment.

Pikilidou MI, Lasaridis AN, Sarafidis PA, Tziolas IM, Zebekakis PE, Dombros NV, Giannoulis E.

Clin Exp Hypertens. 2007 Nov;29(8):563-73.

PMID:
18058481
19.

Combined effect of cerebral hypoperfusion and white matter lesions on executive functioning - The SMART-MR study.

Appelman AP, van der Graaf Y, Vincken KL, Mali WP, Geerlings MI.

Dement Geriatr Cogn Disord. 2010;29(3):240-7. doi: 10.1159/000289813.

PMID:
20375504
20.

The impact of hypertension on cerebral perfusion and cortical thickness in older adults.

Alosco ML, Gunstad J, Xu X, Clark US, Labbe DR, Riskin-Jones HH, Terrero G, Schwarz NF, Walsh EG, Poppas A, Cohen RA, Sweet LH.

J Am Soc Hypertens. 2014 Aug;8(8):561-70. doi: 10.1016/j.jash.2014.04.002.

Items per page

Supplemental Content

Support Center